D-1177-2022 Class II Ongoing
FDA drug recall D-1177-2022 was initiated by Golden State Medical Supply Inc. on Mar 16, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 1,471 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 13, 2022
- Initiation Date
- Mar 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,471 bottles
Product description
Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA, USA.
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
Code information
Lots: GS028301, 2.5 mg; 90 tablets, Exp.: 06/2022; Lots: GS029973, GS029974, GS031436, GS031715, GS033191, GS033940, Exp. : 10/2022; Lot: GS034212, Exp.: 12/2022; Lot: GS035315, GS035945, GS036905, GS038038, GS039199, Exp.: 04/2023; Lot: GS039200, GS040149, Exp.: 11/2023. (NDC: 60429-183-90).
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1177-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026